Adolf D. Berhane

Array ( [id] => 6150019 [patent_doc_number] => 20110021614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'USE OF SILYMARIN AND SILYBIN IN THE TREATMENT OF NEURAL INJURY' [patent_app_type] => utility [patent_app_number] => 12/754305 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4155 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021614.pdf [firstpage_image] =>[orig_patent_app_number] => 12754305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128236 [patent_doc_number] => 20110086913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'METHODS FOR TREATING MYOFASCIAL, MUSCLE, AND/OR BACK PAIN' [patent_app_type] => utility [patent_app_number] => 12/752384 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4070 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086913.pdf [firstpage_image] =>[orig_patent_app_number] => 12752384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543500 [patent_doc_number] => 08318793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/748875 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20212 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12748875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568995 [patent_doc_number] => 20100234408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF NEUROFIBROMATOSIS' [patent_app_type] => utility [patent_app_number] => 12/730590 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5476 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234408.pdf [firstpage_image] =>[orig_patent_app_number] => 12730590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227545 [patent_doc_number] => 08633212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Inhibitors of beta-secretase' [patent_app_type] => utility [patent_app_number] => 12/723137 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 231883 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953991 [patent_doc_number] => 20110034432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/722936 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43575 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034432.pdf [firstpage_image] =>[orig_patent_app_number] => 12722936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424425 [patent_doc_number] => 20100168071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN' [patent_app_type] => utility [patent_app_number] => 12/722967 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2719 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168071.pdf [firstpage_image] =>[orig_patent_app_number] => 12722967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090467 [patent_doc_number] => 20110218170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'USE OF 2\'-DEOXY-4\'-THIOCYTIDINE AND ITS ANALOGUES AS DNA HYPOMETHYLATING ANTICANCER AGENTS' [patent_app_type] => utility [patent_app_number] => 12/715811 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6178 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218170.pdf [firstpage_image] =>[orig_patent_app_number] => 12715811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375844 [patent_doc_number] => 08680109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Combination product comprising SRC kinase inhibitor AZDO530 and an antioestrogen or EGFR-TK-inhibitor' [patent_app_type] => utility [patent_app_number] => 12/714997 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14709 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12714997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550775 [patent_doc_number] => 08063108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Method for modulating microbial quorum sensing' [patent_app_type] => utility [patent_app_number] => 12/712948 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 9993 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063108.pdf [firstpage_image] =>[orig_patent_app_number] => 12712948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6444215 [patent_doc_number] => 20100144639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'USE OF INHIBITORS OF THE EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) / PROSTATIC HYPERTROPHY' [patent_app_type] => utility [patent_app_number] => 12/706819 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5743 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144639.pdf [firstpage_image] =>[orig_patent_app_number] => 12706819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136453 [patent_doc_number] => 20110009378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy' [patent_app_type] => utility [patent_app_number] => 12/706321 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33527 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009378.pdf [firstpage_image] =>[orig_patent_app_number] => 12706321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626654 [patent_doc_number] => 08796334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Methods of treating hair related conditions' [patent_app_type] => utility [patent_app_number] => 13/201790 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 9454 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663785 [patent_doc_number] => 20110313054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'BRANCHED COPOLYMERS, COMPOSITION AND USES' [patent_app_type] => utility [patent_app_number] => 13/148470 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9792 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313054.pdf [firstpage_image] =>[orig_patent_app_number] => 13148470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6508228 [patent_doc_number] => 20100286585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Shunt Delivery of Curcumin' [patent_app_type] => utility [patent_app_number] => 12/696588 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 6119 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286585.pdf [firstpage_image] =>[orig_patent_app_number] => 12696588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561764 [patent_doc_number] => 20110275597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/143808 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5968 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275597.pdf [firstpage_image] =>[orig_patent_app_number] => 13143808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993522 [patent_doc_number] => 20110015175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Bicyclic Compounds for the Reduction of Beta-Amyloid Production' [patent_app_type] => utility [patent_app_number] => 12/683791 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77938 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015175.pdf [firstpage_image] =>[orig_patent_app_number] => 12683791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140947 [patent_doc_number] => 20120095024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'TOLUIDINE SULFONAMIDES AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/142519 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23890 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095024.pdf [firstpage_image] =>[orig_patent_app_number] => 13142519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314885 [patent_doc_number] => 20100112070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Composition and dosage form comprising a particle formulation and suspending vehicle' [patent_app_type] => utility [patent_app_number] => 12/655397 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14889 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112070.pdf [firstpage_image] =>[orig_patent_app_number] => 12655397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929859 [patent_doc_number] => 20110039818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Dosage regimen of an S1P receptor agonist' [patent_app_type] => utility [patent_app_number] => 12/655049 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9517 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039818.pdf [firstpage_image] =>[orig_patent_app_number] => 12655049 [rel_patent_id] =>[rel_patent_doc_number] =>)